Emtiazy Majid, Oveidzadeh Laleh, Habibi Minoo, Molaeipour Leila, Talei Daryush, Jafari Zahra, Parvin Mahmoud, Kamalinejad Mohammad
1Department of Persian Medicine, The School of Persian Medicine, Shahid Sadoughi University of Medical Sciences, Ardakan, Yazd Iran.
2Internal Medicine, Pulmonary Ward, Labbafi Nezhad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Allergy Asthma Clin Immunol. 2018 May 2;14:19. doi: 10.1186/s13223-018-0238-9. eCollection 2018.
Asthma is one of the important chronic diseases. The asthma prevalence is increasing in last decades. Despite the presence of good controller drugs like corticosteroids, about 60% of asthmatic patients use alternative medicine. This study was done to determine the effectiveness of (fenugreek) seeds in mild asthma.
It is a double blind trial with placebo effect. One of the ancient prescriptions from Persian Medicine was selected. The participants were divided to three groups randomly. On group received fenugreek syrup one received honey syrup and the third received placebo. Duration of treatment was 4 weeks. Quality of life, Lung function tests and IL-4 levels were evaluated before and after treatment.
From 90 participants to study 79 completed the process. After study there was significant increase in quality of the life and lung function tests and IL-4 levels in fenugreek and honey groups.
FEV1 level was improved more than 10% in fenugreek group. Treatment was well tolerated. No serious side effects were reported during the study. The aqueous extract of fenugreek seeds appears to be effective and safe in treatment of mild asthma. The study was recorded with the Iranian Registry of Clinical trials [http://www.irci.ir], registration code: IRCT2016011325991N1.
哮喘是重要的慢性疾病之一。在过去几十年中,哮喘患病率呈上升趋势。尽管有像皮质类固醇这样的有效控制药物,但仍有大约60%的哮喘患者使用替代药物。本研究旨在确定胡芦巴种子对轻度哮喘的疗效。
这是一项具有安慰剂效应的双盲试验。选择了一种来自波斯医学的古老处方。参与者被随机分为三组。一组接受胡芦巴糖浆,一组接受蜂蜜糖浆,第三组接受安慰剂。治疗持续时间为4周。在治疗前后评估生活质量、肺功能测试和白细胞介素-4水平。
90名参与研究的参与者中有79名完成了整个过程。研究结束后,胡芦巴组和蜂蜜组的生活质量、肺功能测试及白细胞介素-4水平均有显著提高。
胡芦巴组的第一秒用力呼气容积(FEV1)水平提高超过10%。治疗耐受性良好。研究期间未报告严重副作用。胡芦巴种子水提取物在治疗轻度哮喘方面似乎有效且安全。该研究已在伊朗临床试验注册中心[http://www.irci.ir]注册,注册号:IRCT2016011325991N1。